{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:09:33Z","timestamp":1793844573755,"version":"4.6.1"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Acute and chronic pain represents an escalating public health concern, necessitating safer and more effective in-hospital management approaches, including mental health. New treatment combinations involving psycholeptics are rising, but real-world evidence is lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>The study's primary objective is to evaluate the impact of combined opioid analgesics and antipsychotics in-hospital medication on pain modulation. The secondary objective is to evaluate pain management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The cross-sequential study designed by this protocol will analyze retrospective data on 5,000 hospital admissions over four years (2019\u20132023) gathered from Electronic Health Records (EHR) of a multisite hospital in southern Switzerland. Eligible patients are aged 18 or older and hospitalized in an Internal Medicine ward. All patients with documented pain intensity assessment through a Visual Analogue Scale (VAS\u2009\u2265\u20091) will be included. Cross-sectional data on demographic and clinical variables and type of medication (opioid analgesics, antipsychotics, and selected other drugs according to the Anatomical Therapeutic Chemical classification system) will be screened at hospital admission (T1) and discharge (T2). Pain modulation will be assessed by gravity (VAS mean), intensity (VAS peak\/extreme value), and pain treatment effectiveness (<jats:italic>\u0394<\/jats:italic>T2-T1 VAS). Hospitalization paths (short- and long-term readmissions and total length of hospital stays) will be scrutinized as additional longitudinal indices for pain management and excluded from the cross-sectional analysis. A mixed model approach will assess VAS changes from T1 to T2. Logistic regression and regression models for count data will be used for short- and long-term readmission, respectively. Propensity score matching will be used to mitigate selection bias.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This methodological approach combines cross-sectional and longitudinal EHR data gathering in a cross-sequential design. This integration allows for a comprehensive examination of pain modulation and management among internal medicine recipients of concomitant opioids and antipsychotic treatment, spanning both hospitalization and post-discharge periods. By leveraging EHR data, the study protocol ensures reliability and standardization while minimizing missing information. Additionally, the protocol addresses the potential limitations of observational designs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This method offers a comprehensive and rigorous approach to investigating pain modulation and management in internal medicine patients receiving combined opioid analgesics and antipsychotics, with potential implications for enhancing clinical practice and healthcare resource utilization.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpain.2025.1500422","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T06:04:03Z","timestamp":1744092243000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The impact of opioid analgesics with concomitant antipsychotic use on pain modulation and management in internal medicine: a cross-sequential study protocol"],"prefix":"10.3389","volume":"6","author":[{"given":"Nicola","family":"Grignoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Livoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Pironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Noseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Ceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Garo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gabutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e17838","DOI":"10.7759\/cureus.17838","article-title":"Pain in an internal medicine ward: an undervalued reality?","volume":"13","author":"Eg\u00eddio de Sousa","year":"2021","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.7417\/CT.2022.2411","article-title":"Pain prevalence in two Italian hospitals. An observational study","volume":"173","author":"Mitello","year":"2022","journal-title":"Clin Ter"},{"key":"B3","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1177\/1049909114530491","article-title":"The barriers to high-quality inpatient pain management","volume":"32","author":"Lin","year":"2015","journal-title":"Am J Hosp Palliat Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/j.1526-4637.2010.00983.x","article-title":"Causes and consequences of inadequate management of acute pain","volume":"11","author":"Sinatra","year":"2010","journal-title":"Pain Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/pme.12871","article-title":"Attitudes of primary care practitioners in managing chronic pain patients prescribed opioids for pain: a prospective longitudinal controlled trial","volume":"17","author":"Jamison","year":"2015","journal-title":"Pain Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12875-015-0264-3","article-title":"Decision support for chronic pain care: how do primary care physicians decide when to prescribe opioids? A qualitative study","volume":"16","author":"Harle","year":"2015","journal-title":"BMC Fam Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/S0140-6736(23)00669-4","article-title":"Europe Has much to do to improve the quality of and access to safe pain management","volume":"401","author":"Forget","year":"2023","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/JAMAPSYCHIATRY.2018.3126","article-title":"Prevention and treatment of opioid misuse and addiction: a review","volume":"76","author":"Volkow","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e028409","DOI":"10.1136\/bmjopen-2018-028409","article-title":"Hospital readmission risk prediction based on claims data available at admission: a pilot study in Switzerland","volume":"9","author":"Br\u00fcngger","year":"2019","journal-title":"BMJ Open"},{"key":"B10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/17843286.2017.1293311","article-title":"Is pain at discharge a risk factor for unplanned hospital readmission?","volume":"72","author":"Deschepper","year":"2017","journal-title":"Acta Clin Belg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s11606-017-4041-y","article-title":"Using a self-reported global health measure to identify patients at high risk for future healthcare utilization","volume":"32","author":"Blumenthal","year":"2017","journal-title":"J Gen Intern Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12888-016-1100-6","article-title":"Why are hospital doctors not referring to consultation-liaison psychiatry? \u2013 a systemic review","volume":"16","author":"Chen","year":"2016","journal-title":"BMC Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.neuron.2015.06.005","article-title":"Nociception, pain, negative moods, and behavior selection","volume":"87","author":"Baliki","year":"2015","journal-title":"Neuron"},{"key":"B14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/j.pain.0000000000001360","article-title":"The IASP classification of chronic pain for ICD-11","volume":"160","author":"Smith","year":"2019","journal-title":"Pain"},{"key":"B15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/1467-8721.00032","article-title":"Pain: biopsychosocial mechanisms and management","volume":"8","author":"Keefe","year":"1999","journal-title":"Curr Dir Psychol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41591-023-02430-4","article-title":"A prognostic risk score for development and spread of chronic pain","volume":"29","author":"Tanguay-Sabourin","year":"2023","journal-title":"Nat Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","article-title":"Nociplastic pain: towards an understanding of prevalent pain conditions","volume":"397","author":"Fitzcharles","year":"2021","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"T70","DOI":"10.1016\/J.JPAIN.2016.01.001","article-title":"The role of psychosocial processes in the development and maintenance of chronic pain disorders","volume":"17","author":"Edwards","year":"2016","journal-title":"J Pain"},{"key":"B19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/9781119701170.ch11","article-title":"Psychological assessment of persons with chronic pain","volume-title":"Clinical Pain Management","author":"Jamison","year":"2022"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e767","DOI":"10.1097\/PR9.0000000000000767","article-title":"Brain mechanisms impacted by psychological therapies for pain: identifying targets for optimization of treatment effects","volume":"4","author":"Cunningham","year":"2019","journal-title":"Pain Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1176\/appi.psy.46.5.379","article-title":"Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain","volume":"46","author":"Krell","year":"2005","journal-title":"Psychosomatics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.pain.2012.01.029","article-title":"An increase in spinal cord noradrenaline is a major contributor to the antihyperalgesic effect of antidepressants after peripheral nerve injury in the rat","volume":"153","author":"Nakajima","year":"2012","journal-title":"Pain"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1517\/14656566.2014.925446","article-title":"Treatment of central sensitization in patients with \u201cunexplained\u201d chronic pain: an update","volume":"15","author":"Nijs","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"B24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/J.PNPBP.2018.07.017","article-title":"Overlaps in pharmacology for the treatment of chronic pain and mental health disorders","volume":"87","author":"Sutherland","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/PH12020099","article-title":"Psychotropic drugs for the management of chronic pain and itch","volume":"12","author":"Belinskaia","year":"2019","journal-title":"Pharmaceuticals"},{"key":"B26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","article-title":"Structures of the entire human opioid receptor family","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.nurx.2005.12.003","article-title":"How antipsychotics work\u2014from receptors to reality","volume":"3","author":"Kapur","year":"2006","journal-title":"NeuroRX"},{"key":"B28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/AJP.0000000000000567","article-title":"A systematic review of atypical antipsychotics in chronic pain management","volume":"34","author":"Jimenez","year":"2018","journal-title":"Clin J Pain"},{"key":"B29","doi-asserted-by":"publisher","first-page":"CD004844","DOI":"10.1002\/14651858.CD004844.pub3","article-title":"Antipsychotics for acute and chronic pain in adults","volume":"2013","author":"Seidel","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41593-021-00971-w","article-title":"Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties","volume":"25","author":"Chen","year":"2021","journal-title":"Nat Neurosci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s41591-023-02337-0","article-title":"Time for real-world health data to become routine","volume":"29","author":"Abernethy","year":"2023","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/0470013192.bsa110","article-title":"Cohort sequential design","volume-title":"Encyclopedia of Statistics in Behavioral Science","author":"Prinzie","year":"2005"},{"key":"B33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/acprof:oso\/9780195092424.003.0007","article-title":"Cross-sectional studies","volume-title":"Research Methods in Occupational Epidemiology","author":"Checkoway","year":"2004"},{"key":"B34","volume-title":"STROBE Statement. Strengthening the reporting of observational studies in epidemiology","year":"2024"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e000048","DOI":"10.1136\/BMJOPEN-2010-000048","article-title":"Uses and misuses of the STROBE statement: bibliographic study","volume":"1","author":"Da Costa","year":"2011","journal-title":"BMJ Open"},{"key":"B36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0304-3959(83)90126-4","article-title":"The validation of visual analogue scales as ratio scale measures for chronic and experimental pain","volume":"17","author":"Price","year":"1983","journal-title":"Pain"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.57187\/s.3409","article-title":"A swiss hospital network facing antipsychotic, benzodiazepine and Z-drug prescriptions in the choosing wisely and COVID-19 era: a cross-sectional study","volume":"154","author":"Gagliano","year":"2024","journal-title":"Swiss Med Wkly"},{"key":"B38","article-title":"ATCvet Index. 2023","year":"2023"},{"key":"B39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/978-3-642-28753-4_102537","article-title":"WHO analgesic ladder","volume":"38","author":"Anekar","year":"2023","journal-title":"J R Coll Physicians Edinb"},{"key":"B40","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2174\/138161210790361461","article-title":"Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?","volume":"16","author":"Mailman","year":"2010","journal-title":"Curr Pharm Des"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1016\/j.pain.2014.09.014","article-title":"Cut-off points for mild, moderate, and severe pain on the visual analogue scale for pain in patients with chronic musculoskeletal pain","volume":"155","author":"Boonstra","year":"2014","journal-title":"Pain"},{"key":"B42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12874-017-0338-0","article-title":"Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance","volume":"17","author":"Nguyen","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"B45","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/med\/9780198739685.003.0009","article-title":"Epidemiological study designs and principles of data analysis: a conceptually integrated suite of methods and techniques","volume-title":"Concepts of Epidemiology","author":"Bhopal","year":"2016"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3390\/ijerph20021473","article-title":"Reproducibility and scientific integrity of big data research in urban public health and digital epidemiology: a call to action","volume":"20","author":"Quiroga Gutierrez","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"B47","doi-asserted-by":"publisher","first-page":"108996","DOI":"10.1016\/j.drugalcdep.2021.108996","article-title":"Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: results from a multisite trial of buprenorphine-naloxone and methadone","volume":"228","author":"Zhu","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12888-021-03411-y","article-title":"Factors associated with antipsychotic use in non-psychotic depressed patients: results from a clinical multicenter survey","volume":"22","author":"Zhou","year":"2022","journal-title":"BMC Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.2174\/1570159X17666190430102531","article-title":"Role of descending dopaminergic pathways in pain modulation","volume":"17","author":"Li","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/j.pain.0000000000000494","article-title":"Mesolimbic dopamine signaling in acute and chronic pain","volume":"157","author":"Taylor","year":"2016","journal-title":"Pain"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6682275","article-title":"The distinct functions of dopaminergic receptors on pain modulation: a narrative review","volume":"2021","author":"Wang","year":"2021","journal-title":"Neural Plast"},{"key":"B52","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/syn.20616","article-title":"Human evidence of a supra-spinal modulating role of dopamine on pain perception","volume":"63","author":"Potvin","year":"2009","journal-title":"Synapse"},{"key":"B53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0091-3057(99)00107-0","article-title":"The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency","volume":"64","author":"Schreiber","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"B54","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0304-3940(97)00345-5","article-title":"Augmentation of opioid induced antinociception by the atypical antipsychotic drug risperidone in mice","volume":"228","author":"Schreiber","year":"1997","journal-title":"Neurosci Lett"},{"key":"B55","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ejphar.2015.08.053","article-title":"The antipsychotic aripiprazole induces antinociceptive effects: possible role of peripheral dopamine D2 and serotonin 5-HT1A receptors","volume":"765","author":"Almeida-Santos","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"B56","article-title":"Antipsychotic Medications","volume-title":"StatPearls","author":"Chokhawala","year":"2023"},{"key":"B57","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/00325481.2016.1147925","article-title":"Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics","volume":"128","author":"Khouzam","year":"2016","journal-title":"Postgrad Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1152\/PHYSIOL.00015.2020","article-title":"Multi-level regulation of opioid-induced respiratory depression","volume":"35","author":"Palkovic","year":"2020","journal-title":"Physiology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1111\/PME.12912","article-title":"Cognitive effects and sedation","volume":"16","author":"Dhingra","year":"2015","journal-title":"Pain Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/SCHBUL\/SBAB116","article-title":"Risk of overdose associated with co-prescription of antipsychotics and opioids: a population-based cohort study","volume":"48","author":"Szmulewicz","year":"2022","journal-title":"Schizophr Bull"},{"key":"B61","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.enfcli.2018.11.004","article-title":"Prevalencia, manejo y registro del dolor en unidades de Medicina Interna","volume":"30","author":"Mu\u00f1oz-Alvaredo","year":"2020","journal-title":"Enferm Clin"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/S0140-6736(22)01594-X","article-title":"The north American opioid crisis: a European perspective","volume":"400","author":"Kalkman","year":"2022","journal-title":"Lancet"},{"key":"B63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/emj.20.1.54","article-title":"Observational research methods. Research design II: cohort, cross sectional, and case-control studies","volume":"20","author":"Mann","year":"2003","journal-title":"Emerg Med J"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1177\/10600280211003875","article-title":"Pharmacogenomics in pain management: a review of relevant gene-drug associations and clinical considerations","volume":"55","author":"Brandl","year":"2021","journal-title":"Ann Pharmacother"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2025.1500422\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T06:04:30Z","timestamp":1744092270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2025.1500422\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":64,"alternative-id":["10.3389\/fpain.2025.1500422"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2025.1500422","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"article-number":"1500422"}}